News
Researchers at Oregon Health and Science University found that variability in the harmonic-to-noise ratio (HNR) of speech ...
TipRanks on MSN13h
BioNTech’s BNT113 Trial: A Potential Game-Changer in Head and Neck Cancer Treatment
The trial tests BNT113, a biological treatment administered via IV injection, in combination with pembrolizumab, an IV infusion, to enhance therapeutic outcomes for patients with specific head and ...
Q2 2025 Earnings Call Transcript August 13, 2025 PDS Biotechnology Corporation beats earnings expectations. Reported EPS is $ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback